Citigroup
EVH icon

Citigroup’s Evolent Health EVH Stock Holding History

Citigroup’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Buy
812,095
+227,630
+39% +$722K ﹤0.01% 2713
2025
Q4 		$2.34M Sell
584,465
-279,188
-32% -$1.55M ﹤0.01% 2553
2025
Q3 		$7.31M Buy
863,653
+675,424
+359% +$6.55M ﹤0.01% 1718
2025
Q2 		$2.12M Sell
188,229
-331,530
-64% -$3.04M ﹤0.01% 2591
2025
Q1 		$4.92M Buy
519,759
+168,646
+48% +$1.7M ﹤0.01% 1908
2024
Q4 		$3.95M Buy
351,113
+204,220
+139% +$3.59M ﹤0.01% 2196
2024
Q3 		$4.15M Buy
146,893
+120,129
+449% +$3.1M ﹤0.01% 2010
2024
Q2 		$512K Buy
26,764
+6,722
+34% +$172K ﹤0.01% 3378
2024
Q1 		$657K Buy
20,042
+2,054
+11% +$65.5K ﹤0.01% 3371
2023
Q4 		$594K Buy
17,988
+16,402
+1,034% +$464K ﹤0.01% 3270
2023
Q3 		$43.2K Sell
1,586
-35,101
-96% -$976K ﹤0.01% 4185
2023
Q2 		$1.11M Sell
36,687
-5,985
-14% -$194K ﹤0.01% 2769
2023
Q1 		$1.38M Buy
42,672
+38,176
+849% +$1.21M ﹤0.01% 2299
2022
Q4 		$126K Sell
4,496
-1,165
-21% -$33.4K ﹤0.01% 3931
2022
Q3 		$204K Sell
5,661
-5,075
-47% -$179K ﹤0.01% 3774
2022
Q2 		$329K Buy
10,736
+1,115
+12% +$32.5K ﹤0.01% 3545
2022
Q1 		$311K Sell
9,621
-30,484
-76% -$798K ﹤0.01% 3822
2021
Q4 		$1.11M Sell
40,105
-14,455
-26% -$415K ﹤0.01% 3138
2021
Q3 		$1.69M Sell
54,560
-4,106
-7% -$98.6K ﹤0.01% 2677
2021
Q2 		$1.24M Sell
58,666
-5,483
-9% -$110K ﹤0.01% 3063
2021
Q1 		$1.29M Sell
64,149
-23,562
-27% -$448K ﹤0.01% 2789
2020
Q4 		$1.41M Buy
87,711
+11,896
+16% +$157K ﹤0.01% 3207
2020
Q3 		$941K Buy
75,815
+30,995
+69% +$364K ﹤0.01% 3324
2020
Q2 		$319K Sell
44,820
-40,276
-47% -$270K ﹤0.01% 4642
2020
Q1 		$462K Buy
85,096
+23,762
+39% +$212K ﹤0.01% 3931
2019
Q4 		$554K Buy
61,334
+32,997
+116% +$268K ﹤0.01% 4341
2019
Q3 		$204K Sell
28,337
-1,125,918
-98% -$8.08M ﹤0.01% 5134
2019
Q2 		$9.18M Buy
1,154,255
+1,131,265
+4,921% +$13.4M 0.01% 1460
2019
Q1 		$289K Sell
22,990
-57,891
-72% -$917K ﹤0.01% 4738
2018
Q4 		$1.61M Sell
80,881
-6,442
-7% -$149K ﹤0.01% 2883
2018
Q3 		$2.48M Buy
87,323
+84,320
+2,808% +$2.01M ﹤0.01% 2536
2018
Q2 		$64K Buy
3,003
+414
+16% +$7.84K ﹤0.01% 6092
2018
Q1 		$37K Sell
2,589
-202
-7% -$2.89K ﹤0.01% 6380
2017
Q4 		$35K Buy
2,791
+52
+2% +$733 ﹤0.01% 6408
2017
Q3 		$49K Sell
2,739
-63
-2% -$1.3K ﹤0.01% 6008
2017
Q2 		$72K Sell
2,802
-3,971
-59% -$95.5K ﹤0.01% 5560
2017
Q1 		$151K Sell
6,773
-99
-1% -$1.9K ﹤0.01% 4890
2016
Q4 		$102K Buy
6,872
+5,452
+384% +$107K ﹤0.01% 5760
2016
Q3 		$35K Buy
1,420
+1,335
+1,571% +$31.2K ﹤0.01% 5891
2016
Q2 		$2K Sell
85
-9,175
-99% -$126K ﹤0.01% 6918
2016
Q1 		$98K Buy
9,260
+5,275
+132% +$54.5K ﹤0.01% 5674
2015
Q4 		$48K Buy
3,985
+3,473
+678% +$51.2K ﹤0.01% 5965
2015
Q3 		$8K Buy
512
+12
+2% +$234 ﹤0.01% 6536
2015
Q2 		$10K Buy
+500
New +$9.32K ﹤0.01% 6457

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup's EVH Position: Q1 2026 in Review

Citigroup increased its Evolent Health (EVH) stake by 39% in Q1 2026, buying an estimated $722K and bringing the position to 812,095 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2713.

Citigroup first reported a position in EVH in Q2 2015 and has held it in 44 quarters since. The position peaked at $9.18M in Q2 2019. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Citigroup held 812,095 shares of Evolent Health worth $1.85M as of Q1 2026.
  • Citigroup bought 227,630 Evolent Health shares in Q1 2026, an estimated $722K.
  • Evolent Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2713 holding.
  • Citigroup first reported a position in Evolent Health in Q2 2015 and has held it in 44 quarters since.
  • Citigroup's Evolent Health position peaked at $9.18M in Q2 2019.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.